Relationship between CD4 count and quality of life over time among HIV patients in Uganda: A cohort study

Mwesigire, Doris Mutabazi; Martin, Faith; Seeley, Janet; Katamba, Achilles

Abstract

© 2015 Mwesigire et al. Background: Immunological markers (CD4 count) are used in developing countries to decide on initiation of antiretroviral therapy and monitor HIV/AIDS disease progression. HIV is an incurable chronic illness, making quality of life paramount. The direct relationship between quality of life and CD4 count is unclear. The purpose of this study is to determine the relationship between change in CD4 count and quality of life measures in a Ugandan cohort of people living with HIV. Methods: We prospectively assessed quality of life among 1274 HIV patients attending an HIV clinic within a national referral hospital over a period of 6months. Quality of life was measured using an objective measure, the Medical Outcomes Study HIV health survey summarized as Physical Health Score and Mental Health Score and a subjective measure, the Global Person Generated Index. Generalized estimating equations were used to analyze the data. The primary predictor variable was change in CD4 count, and the outcome was quality of life scores. We controlled for sociodemographic characteristics, clinical factors and behavioral factors. Twenty in-depth interviews were conducted to assess patient perception of quality of life and factors influencing quality of life. Results: Of the 1274 patients enrolled 1159 had CD4 count at baseline and six months and 586 (51%) received antiretroviral therapy. There was no association found between change in CD4 count and quality of life scores at univariate and multivariate analysis among the study participants whether on or not on antiretroviral therapy. Participants perceived quality of life as happiness and well-being, influenced by economic status, psychosocial factors, and health status. Conclusions: Clinicians and policy makers cannot rely on change in immunological markers to predict quality of life in this era of initiating antiretroviral therapy among relatively healthy patients. In addition to monitoring immunological markers, socioeconomic and psychosocial factors should be underscored in management of HIV patients.

• Journal Article Type: Article
• Acceptance Date: Aug 23, 2015
• Online Publication Date: Sep 15, 2015
• Publication Date: Sep 15, 2015
• Deposit Date: Sep 18, 2019
• Publicly Available Date: Sep 18, 2019
• Journal: Health and Quality of Life Outcomes
• Electronic ISSN: 1477-7525
• Publisher: BioMed Central
• Peer Reviewed: Peer Reviewed
• Volume: 13
• Issue: 1
• Article Number: 144
• DOI: https://doi.org/10.1186/s12955-015-0332-3
• Public URL: https://uwe-repository.worktribe.com/output/3069624
• Contract Date: Sep 18, 2019